Stem cell models of cardiac development and disease

Annual Review of Cell and Developmental Biology

Volumn 26, Issue , 2010, Pages 667-687

  Musunuru, Kiran ^a   Domian, Ibrahim J ^a   Chien, Kenneth R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cardiovascular disease; congenital heart disease; coronary disease; embryonic stem cells; genetics; induced pluripotent stem cells; myocardial infarction

Indexed keywords

CELL ISOLATION; CONGENITAL HEART DISEASE; DNA MODIFICATION; EMBRYONIC STEM CELL; GENETIC ANALYSIS; HEART DEVELOPMENT; HEART DISEASE; HUMAN; MULTIPOTENT STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; GENETICS; HEART; HEART MUSCLE; PATHOLOGY; PRENATAL DEVELOPMENT;

HOMEODOMAIN PROTEIN; INSULIN GENE ENHANCER BINDING PROTEIN ISL 1; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1;

ANIMALS; HEART; HEART DISEASES; HOMEODOMAIN PROTEINS; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIUM; STEM CELLS;

EID: 78049380899     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-cellbio-100109-103948     Document Type: Review

References (103)

1. Agarwal S, Holton KL, Lanza R. 2008. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 26:1117-27
2. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, et al. 2000. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227:271-78
3. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, et al. 1997. Mutations in human TBX5 cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet. 15:30-35
4. Benson DW, Silberbach GM, Kavanaugh-McHughA,CottrillC,ZhangY,etal. 1999. Mutations inthe cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 104:1567-73
5. Bruneau BG. 2008. The developmental genetics of congenital heart disease. Nature 451:943-48
6. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, et al. 2001. A murine model of Holt-Oramsyndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106:709-21
7. Brunet E, Simsek D, Tomishima M, DeKelver R, Choi VM, et al. 2009. Chromosomal translocations inducedat specified loci in human stem cells. Proc. Natl. Acad. Sci. USA 106:10620-25
8. Bu L, Gao X, Jiang X, Chien KR, Wang Z. 2010. Targeted conditional gene knockout in human embryonicstem cells. Cell Res. 20:379-82
9. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, et al. 2009. Human ISL1 heart progenitors generate diversemultipotent cardiovascular cell lineages. Nature 460:113-17
10. Buckingham M, Meilhac S, Zaffran S. 2005. Building the mammalian heart from two sources of myocardialcells. Nat. Rev. Genet. 6:826-35
11. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, et al. 2003. Isl1 identifies a cardiac progenitor population thatproliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 5:877-89
12. Cai J, Zhao Y, Liu Y, Ye F, Song Z, et al. 2007. Directed differentiation of human embryonic stem cells intofunctional hepatic cells. Hepatology 45:1229-39
13. Chien KR. 2008. Regenerative medicine and human models of human disease. Nature 453:302-5
14. Chien KR, Domian IJ, Parker KK. 2008. Cardiogenesis and the complex biologyof regenerative cardiovascularmedicine. Science 322:1494-97
15. Costa M, Dottori M, Sourris K, Jamshidi P, Hatzistavrou T, et al. 2007. A method for genetic modificationof human embryonic stem cells using electroporation. Nat. Protoc. 2:792-96
16. Davis RP, Ng ES, Costa M, Mossman AK, Sourris K, et al. 2008. Targeting a GFP reporter gene to theMIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enablesisolation of primitive hematopoietic precursors. Blood 111:1876-84
17. Di Domenico AI, Christodoulou I, Pells SC, McWhir J, Thomson AJ. 2008. Sequential genetic modificationof the hprt locus in human ESCs combining gene targeting and recombinase-mediated cassette exchange.Cloning Stem. Cells 10:217-30
18. Dodou E, Verzi MP, Anderson JP, Xu SM, Black BL. 2004. Mef2c is a direct transcriptional target of ISL1 andGATA factors in the anterior heartfield during mouse embryonic development. Development 131:3931-42
19. Domian IJ, Chiravuri M, van der MeerP,Feinberg AW, ShiX, et al. 2009. Generation of functional ventricularheart muscle from mouse ventricular progenitor cells. Science 326:426-29
20. Dyer LA, Kirby ML. 2009. The role of secondary heart field in cardiac development. Dev. Biol. 336:137-44
21. Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, Benvenisty N. 2001. Establishment of humanembryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 11:514-18
22. Eldadah ZA, Hamosh A, Biery NJ, Montgomery RA, Duke M, et al. 2001. Familial tetralogy of Fallot causedby mutation in the jagged1 gene. Hum. Mol. Genet. 10:163-69
23. Elliott DA, Kirk EP, Yeoh T, Chandar S, McKenzie F, et al. 2003. Cardiac homeobox gene NKX2-5 mutationsand congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J.Am. Coll. Cardiol. 41:2072-76
24. Erdmann J, Grosshennig A, Braund PS, Konig IR, Hengstenberg C, et al. 2009. New susceptibility locus forcoronary artery disease on chromosome 3q22.3. Nat. Genet. 41:280-82
25. Farrell M, Waldo K, Li YX, Kirby ML. 1999. A novel role for cardiac neural crest in heart development.Trends Cardiovasc. Med. 9:214-20
26. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, et al. 2003. GATA4 mutations cause humancongenital heart defects and reveal an interaction with TBX5. Nature 424:443-47
27. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, et al. 2005. Mutations in NOTCH1 cause aorticvalve disease. Nature 437:270-74
28. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, et al. 1998. Frequency of 22q11 deletions inpatients with conotruncal defects. J. Am. Coll. Cardiol. 32:492-98
29. Goldmuntz E, Geiger E, Benson DW. 2001. NKX2.5 mutations in patients with tetralogy of Fallot. Circulation 104:2565-68
30. Goldstein JL, Brown MS. 2009. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 29:431-38
31. Greenway SC, Pereira AC, Lin JC, DePalma SR, Israel SJ, et al. 2009. De novo copy number variants identifynew genes and loci in isolated sporadic tetralogy of Fallot. Nat. Genet. 41:931-35
32. Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, et al. 2009. Sequence variants affectingeosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41:342-47
33. Gutierrez-Roelens I, Sluysmans T, Gewillig M, Devriendt K, Vikkula M. 2002. Progressive AV-block andanomalous venous return among cardiac anomalies associated with two novel missense mutations in theCSX/NKX2-5 gene. Hum. Mutat. 20:75-76
34. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, et al. 2008. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranialaneurysm. Nat. Genet. 40:217-24
35. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al. 2007. A common variant onchromosome 9p21 affects the risk of myocardial infarction. Science 316:1491-93
36. Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, Nakamura Y, et al. 2005. Phenotypes with GATA4or NKX2.5 mutations in familial atrial septal defect. Am. J. Med. Genet. A 135:47-52
37. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, et al. 2001. Tbx5 associates with Nkx2-5 and synergisti call ypromotes cardiomyocyte differentiation. Nat. Genet. 28:276-80
38. Ikeda Y, Hiroi Y, Hosoda T, Utsunomiya T, Matsuo S, et al. 2002. Novel point mutation in the cardiactranscription factor CSX/NKX2.5 associated with congenital heart disease. Circ. J. 66:561-63
39. Irion S, Luche H, Gadue P, Fehling HJ, Kennedy M, Keller G. 2007. Identification and targeting of theROSA26 locus in human embryonic stem cells. Nat. Biotechnol. 25:1477-82
40. Kasahara H, Benson DW. 2004. Biochemical analyses of eight NKX2.5 homeodomain missense mutationscausing atrioventricular block and cardiac anomalies. Cardiovasc. Res. 64:40-51
41. Kasahara H, Lee B, Schott JJ, Benson DW, Seidman JG, et al. 2000. Loss of function and inhibitory effects ofhuman CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J. Clin. Invest.106:299-308
42. + cardiovascular progenitor cells give rise to thecardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11:723-32
43. Kirk EP, Sunde M, Costa MW, Rankin SA, Wolstein O, et al. 2007. Mutations in cardiac T-box factor geneTBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesisand cardiomyopathy. Am. J. Hum. Genet. 81:280-91
44. Kouskoff V, Lacaud G, Schwantz S, Fehling HJ, Keller G. 2005. Sequential development of hematopoietic andcardiac mesoderm during embryonic stem cell differentiation. Proc. Natl. Acad. Sci. USA 102:13170-75
45. Krantz ID, Smith R, Colliton RP, Tinkel H, Zackai EH, et al. 1999. Jagged1 mutations in patients ascertainedwith isolated congenital heart defects. Am. J. Med. Genet. 84:56-60
46. Kwon C, Arnold J, Hsiao EC, Taketo MM, Conklin BR, Srivastava D. 2007. Canonical wnt signaling is apositive regulator of mammalian cardiac progenitors. Proc. Natl. Acad. Sci. USA 104:10894-99
47. + cardioblasts enter fullydifferentiated cardiomyocyte lineages. Nature 433:647-53
48. Lee HJ, Kim E, Kim JS. 2010. Targeted chromosomal deletions in human cells using zinc finger nucleases.Genome Res. 20:81-89
49. Li L, Krantz ID, Deng Y, Genin A, Banta AB, et al. 1997a. Alagille syndrome is caused by mutations in humanJagged1, which encodes a ligand for Notch1. Nat. Genet. 16:243-51
50. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, et al. 1997b. Holt-Oram syndrome is causedby mutations in TBX5, a member of the Brachyury (T) gene family. Nat. Genet. 15:21-29
51. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, et al. 2001. Tbx1 haploinsufficiency in the DiGeorgesyndrome region causes aortic arch defects in mice. Nature 410:97-101
52. Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee YL, et al. 2007. Gene editing in human stem cellsusing zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25:1298-306
53. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, et al. 1995. Myogenic and morphogenetic defects in theheart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 9:1654-66
54. Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, et al. 2008. Rapid "open-source"engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol. Cell 31:294-301
55. Martin-Puig S, Wang Z, Chien KR. 2008. Lives of a heart cell: tracing the origins of cardiac progenitors. CellStem Cell 2:320-31
56. McDaniell R, Warthen DM, Sanchez-Lara PA, Pai A, Krantz ID, et al. 2006. NOTCH2 mutations causeAlagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 79:169-73
57. McElhinney DB, Geiger E, Blinder J, Benson DW, Goldmuntz E. 2003. NKX2.5 mutations in patients withcongenital heart disease. J. Am. Coll. Cardiol. 42:1650-55
58. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. 2007. A common allele on chromosome9 associated with coronary heart disease. Science 316:1488-91
59. Meilhac SM, Esner M, Kelly RG, Nicolas JF, Buckingham ME. 2004. The clonal origin of myocardial cellsin different regions of the embryonic mouse heart. Dev. Cell 6:685-98
60. Merscher S, Funke B, Epstein JA, Heyer J, Puech A, et al. 2001. TBX1 is responsible for cardiovascular defectsin velo-cardio-facial/DiGeorge syndrome. Cell 104:619-29
61. Meyer N, Jaconi M, Landopoulou A, Fort P, Puceat M. 2000. A fluorescent reporter gene as a marker forventricular specification in ES-derived cardiac cells. FEBS Lett. 478:151-58
62. + progenitorcells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127:1151-65
63. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, et al. 2010. From noncoding variant tophenotype via SORT1 at the 1p13 cholesterol locus. Nature In press
64. Myocardial Infarction Genetics Consortium, Kathiresan S, Voight BF, Purcell S, Musunuru K, et al. 2009.Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms andcopy number variants. Nat. Genet. 41:334-41
65. Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. 1980. Genetic-epidemiologic study ofearly-onset ischemic heart disease. Circulation 61:503-8
66. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, et al. 1997. Mutations in the human Jagged1 geneare responsible for alagille syndrome. Nat. Genet. 16:235-42
67. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, et al. 2008. Perfusion-decellularized matrix: usingnature's platform to engineer a bioartificial heart. Nat. Med. 14:213-21
68. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, et al. 2008a. Disease-specific induced pluripotent stemcells. Cell 134:877-86
69. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, et al. 2008b. Reprogramming of human somatic cells topluripotency with defined factors. Nature 451:141-46
70. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, et al. 2004. Nkx2-5 pathways and congenitalheart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy andcomplete heart block. Cell 117:373-86
71. Pehlivan T, Pober BR, Brueckner M, Garrett S, Slaugh R, et al. 1999. GATA4 haploinsufficiency in patientswith interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am. J. Med. Genet.83:201-6
72. Porteus MH, Baltimore D. 2003. Chimeric nucleases stimulate gene targeting in human cells. Science 300:763
73. Porteus MH, Carroll D. 2005. Gene targeting using zinc finger nucleases. Nat. Biotechnol. 23:967-73
74. Prall OW, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, et al. 2007. An Nkx2-5/Bmp2/Smad1 negativefeedback loop controls heart progenitor specification and proliferation. Cell 128:947-59
75. +cardiovascular progenitors are controlled by a Wnt/β-catenin pathway. Cell Stem Cell 1:165-79
76. Rader DJ, Cohen J, Hobbs HH. 2003. Monogenic hypercholesterolemia: new insights in pathogenesis andtreatment. J. Clin. Invest. 111:1795-803
77. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. 2007. Genomewide association analysisof coronary artery disease. N. Engl. J. Med. 357:443-53
78. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, et al. 1998. Congenital heart disease caused bymutations in the transcription factor NKX2-5. Science 281:108-11
79. Seguin CA, Draper JS, Nagy A, Rossant J. 2008. Establishment of endoderm progenitors by SOX transcriptionfactor expression in human embryonic stem cells. Cell Stem Cell 3:182-95
80. Seidman JG, Seidman C. 2001. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104:557-67
81. Shah M, Akar FG, Tomaselli GF. 2005. Molecular basis of arrhythmias. Circulation 112:2517-29
82. Shiraki N, Umeda K, Sakashita N, Takeya M, Kume K, Kume S. 2008. Differentiation of mouse and humanembryonic stem cells into hepatic lineages. Genes Cells 13:731-46
83. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, et al. 2010. Highly efficient generation of humanhepatocyte-like cells from induced pluripotent stem cells. Hepatology 51:297-305
84. Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, et al. 2007. Thymosin β4 induces adult epicardialprogenitor mobilization and neovascularization. Nature 445:177-82
85. Stevens KN, Hakonarson H, Kim CE, Doevendans PA, Koeleman BP, et al. 2010. Common variation in ISL1confers genetic susceptibility for human congenital heart disease. PLoS One 5:e10855
86. Stevens KR, Pabon L, Muskheli V, Murry CE. 2009. Scaffold-free human cardiac tissue patch created fromembryonic stem cells. Tissue Eng. A 15:1211-22
87. Sun Y, Liang X, Najafi N, Cass M, Lin L, et al. 2007. Islet 1 is expressed in distinct cardiovascular lineages,including pacemaker and coronary vascular cells. Dev. Biol. 304:286-96
88. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. 2007. Induction of pluripotent stem cellsfrom adult human fibroblasts by defined factors. Cell 131:861-72
89. Takeuchi JK, Mileikovskaia M, Koshiba-Takeuchi K, Heidt AB, Mori AD, et al. 2005. Tbx20 dose-dependently regulates transcription factor networks required for mouse heart and motoneuron development. Development 132:2463-74
90. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S. 1999. The cardiac homeobox gene Csx/Nkx2.5 liesgenetically upstream of multiple genes essential for heart development. Development 126:1269-80
91. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. 2010. Biological, clinical, andpopulation relevance of 95 loci for blood lipids. Nature In press
92. Thomas KR, Capecchi MR. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stemcells. Cell 51:503-12
93. Tomita-Mitchell A, Maslen CL, Morris CD, Garg V, Goldmuntz E. 2007. GATA4 sequence variants inpatients with congenital heart disease. J. Med. Genet. 44:779-83
94. Trégouët DA, König IR, Erdmann J, Munteanu A, Braund PS, et al. 2009. Genome-wide haplotype associationstudy identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat.Genet. 41:283-85
95. Urbach A, Schuldiner M, Benvenisty N. 2004. Modeling for Lesch-Nyhan disease by gene targeting in humanembryonic stem cells. Stem Cells 22:635-41
96. Watanabe Y, Benson DW, Yano S, Akagi T, Yoshino M, Murray JC. 2002. Two novel frameshift mutationsin NKX2.5 result in novel features including visceral inversus and sinus venosus type ASD. J. Med. Genet.39:807-11
97. Wu SM, Chien KR, Mummery C. 2008. Origins and fates of cardiovascular progenitor cells. Cell 132:537-43
98. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, et al. 2006. Developmental origin of a bipotentialmyocardial and smooth muscle cell precursor in the mammalian heart. Cell 127:1137-50
99. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, et al. 2003. Role of TBX1 in human del22q11.2syndrome. Lancet 362:1366-73
100. + embryonic-stem-cell-derived population. Nature 453:524-28
101. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. 2007. Induced pluripotent stemcell lines derived from human somatic cells. Science 318:1917-20
102. Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, et al. 2009. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5:97-110
103. Zwaka TP, Thomson JA. 2003. Homologous recombination in human embryonic stem cells. Nat. Biotechnol.21:319-21